High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure

Dual differentiation therapy with arsenic trioxide and tretinoin (all-trans-retinoic acid; ATRA) for the management of low and intermediate risk acute promyelocytic leukemia has recently been recommended by the National Comprehensive Cancer Network. Some less common toxicities of the combination may...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Morgan B., Griffiths, Elizabeth A., Thompson, James E., Wang, Eunice S., Wetzler, Meir, Freyer, Craig W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145165/
https://www.ncbi.nlm.nih.gov/pubmed/25180154
http://dx.doi.org/10.1016/j.lrr.2014.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145165/
https://www.ncbi.nlm.nih.gov/pubmed/25180154
http://dx.doi.org/10.1016/j.lrr.2014.07.001

Ejemplares similares